Article

FDA approves Bausch & Lomb 100 Hz Zyoptix laser

Bausch & Lomb announces that the FDA has approved the 217z100 Zyoptix excimer laser. The 100 Hz laser operates at twice the speed of the company?s current system in both standard and custom treatment modes.

Bausch & Lomb announces that the FDA has approved the 217z100 Zyoptix excimer laser. The 100 Hz laser operates at twice the speed of the company's current system in both standard and custom treatment modes.

The laser - with its unique combination of beam diameters and laser speed - is expected to be commercially available in July, along with an upgrade path to allow current users to access the faster technology.

For more information, visit Bausch & Lomb at Booth 426.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.